Role of nitric oxide in carcinogenesis and tumour progression
Nitric oxide(NO) is a short-lived molecule required for many physiological functions, produced from Larginine by NO synthases (NOS). It is a free radical, producing many reactive …
Nitric oxide(NO) is a short-lived molecule required for many physiological functions, produced from Larginine by NO synthases (NOS). It is a free radical, producing many reactive …
The increasing energy prices and pollutants from fossil fuels that threaten the climate, there is a growing preference for renewable energy. The implementation of hybrid renewable …
… In the LALA-87 trial, overall CR was achieved in 76% of patients (69% after one … in the LALA-94 trial in which we did not find any period effect (data not shown). Better results in the LALA-…
… Members of the GET-LALA Group are listed in the “” at the … Members of the GET-LALA Group are listed in the “” at the end … Members of the GET-LALA Group are listed in the “” at the end …
… Despite their popularity, we now know that LALA … of LALA with P329G gave almost complete elimination of binding to the Fcγ receptors and no detectable ADCC. Combination of LALA …
Evolvability refers to the capacity, ability, or potential of an organism to generate heritable variation. Under this view, much extragenetic inheritance is regarded not as noise, fine-tuning, …
Nitric oxide (NO), a potent biological mediator, plays a key role in physiological as well as pathological processes, including inflammation and cancer. The role of NO in tumor biology …
Please note: This work was supported by U54 TR001433-05, National Center for Advancing Translational Sciences, National Institutes of Health. Dr. Fayad has received consulting fees …
To reveal the relationship between hypodiploidy with 30 to 39 chromosomes and near-triploidy in acute lymphoblastic leukemia (ALL), we studied 24 patients presenting with one of …
Fifty-four percent of adults with acute lymphoblastic leukemia (ALL) who entered the LALA-94 trial experienced a first relapse. We examined the outcome of these 421 adult patients. …